U.S. Insurance Stock News

If you are wondering whether Collegium Pharmaceutical at around US$44.85 is good value or looking fully priced, the key is understanding how its current share price stacks up against a few different valuation checks. The stock has had a mixed run recently, with a 2.1% decline over the last 7 days and a 1.4% decline over the last 30 days, even though the 1 year return sits at 53.6% and the 3 year return at 67.4%. Recent attention on Collegium has focused on its position within the US...

Stock moves and recent performance context Praxis Precision Medicines (PRAX) has drawn fresh attention after recent share price moves. The stock closed at US$342.46 and posted a one-month return of 9.9% and a three-month return of 85.9%. See our latest analysis for Praxis Precision Medicines. Beyond the recent bounce, Praxis Precision Medicines has paired strong short term share price momentum with very large one year and multi year total shareholder returns. This combination suggests...

Recently, the SEC charged Archer-Daniels-Midland and three former executives with accounting and disclosure fraud, alleging improper revenue recognition and misleading financial statements that misinformed investors. This enforcement action raises fresh questions about ADM’s internal controls and governance culture at a time when the company is already facing operational and margin pressures. We’ll now examine how these SEC fraud charges, and the governance concerns they raise, could...

Brown & Brown (NYSE:BRO) has appointed Dorothea “Dori” Henderson as Chief Information Technology Officer. Henderson will lead the company’s technology and AI agenda, with a focus on digital transformation and enterprise systems. Brown & Brown, trading at $69.16, is putting more attention on its technology direction at a time when digital capabilities are central to how insurance distributors operate. The stock shows mixed performance, with a 26.1% return over 3 years and 52.7% over 5 years,...

In the past few days, law firm Kirby McInerney LLP announced it is investigating Alvotech and certain executives for potential federal securities law violations after the FDA issued a complete response letter citing a failed facility inspection for its AVT05 biologics license application. This combination of regulatory setback and investor scrutiny raises fresh questions about Alvotech’s quality controls, regulatory risk management, and disclosure practices around its biosimilar...

Fiverr International (NYSE:FVRR) has restructured its executive team, appointing a new Chief Financial Officer and introducing a Chief Business Officer role. The leadership changes are aimed at addressing rising operational complexity and supporting the company’s long term goals. These moves come as Fiverr faces stronger competitive pressures and continues its push toward serving higher value clients. Fiverr operates a global online marketplace that connects freelancers with businesses...

In the fourth quarter of 2025, Oasis Management Co Ltd. lifted its stake in Hut 8 Corp. by 2,004,953 shares, investing about US$88.38 million and bringing its holding to 2,307,683 shares valued around US$106.01 million. This larger institutional position comes just before Hut 8’s expected report of a US$0.41 loss per share, highlighting contrasting signals around its evolving role beyond a pure Bitcoin mining proxy. Next, we’ll examine how Oasis Management’s expanded position reshapes Hut...

Griffon (GFF) is back in focus after fiscal Q1 results topped expectations, alongside a new AMES North America and Venanpri Tools joint venture, continued share buybacks, and the company’s 58th consecutive quarterly dividend. See our latest analysis for Griffon. Despite a 2.3% one day share price decline and a 7.5% 7 day share price pullback, Griffon’s 30 day and 90 day share price returns of 3.7% and 14.9% respectively, together with a 1 year total shareholder return of 22.4% and a 3 year...

MFA Financial (MFA) is on investor watch after posting annual revenue of US$325.4 million and net income of US$135.7 million, with recent returns mixed over the day, week, month and past 3 months. See our latest analysis for MFA Financial. At a share price of US$9.90, MFA Financial has seen short term share price softness alongside a positive 3 month share price return and a stronger 1 year total shareholder return of 11.27%. This suggests that recent price swings are occurring within a more...

The Trump administration recently invoked the Trade Act of 1974 to impose a 15% global tariff for up to 150 days, raising fresh uncertainty for companies reliant on international supply chains, including IT distributor and solutions provider Ingram Micro Holding. Because Ingram Micro’s core business depends on cross‑border technology distribution and complex global logistics, these tariffs directly challenge how efficiently it can source, price and move products for vendors and customers...

V2X (NYSE:VVX) has secured a position on the US Department of Defense's Advanced Technology Support Program 5. The ATSP5 contract has a ceiling of up to US$25b for defense engineering and advanced technology services. The award opens the door for V2X to compete for mission-focused, AI-driven and modernization projects across the Pentagon. For you as an investor, the ATSP5 award puts V2X directly in the mix for some of the largest engineering and technology projects sponsored by the...

Recent coverage has put Nomad Foods (NOMD) in focus after it received a strong value rating, with valuation ratios such as Forward P/E, P/B, P/S, and P/CF comparing favorably against industry peers. See our latest analysis for Nomad Foods. The recent focus on Nomad Foods' value credentials comes after a mixed run, with a 1 month share price return of 8.57% and year to date share price return of 6.25%, set against a 1 year total shareholder return decline of 28.81% that reflects past weakness...

Spectrum Brands Holdings (SPB) has drawn fresh attention after recent trading left the stock with a one-month return of 22% and a gain of 34.1% over the past three months, sharpening interest in its consumer brands portfolio. See our latest analysis for Spectrum Brands Holdings. That recent run sits on top of a 31.43% year to date share price return as the stock trades at US$78.91. The 1 year total shareholder return of 3.46% and 3 year total shareholder return of 33.70% suggest momentum has...

NasdaqGS:NDAQ has launched the Nasdaq Private Capital Indexes, a new suite of benchmarks for private markets. The indexes aim to provide greater transparency and standardized performance measurement for private capital investments. The launch is designed to serve institutional investors, consultants, and other market participants that use private market data. NasdaqGS:NDAQ operates as a global technology and market infrastructure provider, with data, analytics, and index services sitting...

The U.S. FDA is now reviewing Moderna’s mRNA flu vaccine application after previously issuing a Refusal to File tied to the study’s choice of comparator. This reversal reopens the regulatory path for Moderna’s mRNA flu program, which is part of the company’s broader respiratory vaccine portfolio. The shift follows public criticism of the initial decision and comes at a time when mRNA platforms remain central to Moderna’s long term product plans. For investors watching NasdaqGS:MRNA, this...

Ares Management (NYSE:ARES) has priced its second European direct lending CLO, expanding its private credit activity in the region. The firm is also preparing a new sports, media, and entertainment investment fund aimed at European investors. Both initiatives point to broader plans across European credit and alternative assets. Ares Management, a global alternatives manager, is focusing further on private credit in Europe with a new direct lending CLO while also preparing to target sports,...

Advanced Energy Industries (NasdaqGS:AEIS) is actively pursuing acquisitions to expand its presence, with recent deals focused on industrial and medical technology. Management has highlighted a busy acquisition pipeline and points to recent integration of new technology as evidence that its inorganic growth push is gaining traction. The company is signaling that further deals in industrial and medical markets are a priority, with the goal of reshaping its portfolio around higher value...

Core & Main (CNM) has attracted fresh attention after recent share price moves, with the stock down about 6% over the past week and month, yet showing a positive total return over the past 3 months. See our latest analysis for Core & Main. While the share price is down 6.1% over the last week and 6.7% over the past month, the 90 day share price return of 16.1% and three year total shareholder return of 132.4% suggest longer term momentum has been much stronger than the recent pullback around...

Earnings trigger and why it matters for Atlas Energy Solutions stock Atlas Energy Solutions (AESI) recently reported fourth quarter and full year 2025 results, with quarterly revenue of US$249.43 million and a shift to a net loss compared with profit in the prior year period. See our latest analysis for Atlas Energy Solutions. The earnings-driven swing to a quarterly and full-year loss has been followed by a 1-day share price return of a 6.06% decline and a 7-day return of a 6.54% decline...

Gilead Sciences (NasdaqGS:GILD) has agreed to acquire cancer therapy developer Arcellx in a deal valued at US$7.8b. The transaction will give Gilead full control of anito cel, a late stage CAR T cell therapy for multiple myeloma. An FDA approval decision for anito cel is expected later this year. This is Gilead's largest acquisition since 2020 and expands its presence in oncology and cell therapy. Gilead Sciences is best known for its antiviral and HIV treatments. In recent years it has...

Cognizant Technology Solutions (CTSH) has drawn investor attention after a period of weak share performance, with returns negative over the past month, past 3 months, year to date, and past year. See our latest analysis for Cognizant Technology Solutions. The recent 6% one day share price decline, extending to a 27.38% 30 day share price return and a 26.41% 1 year total shareholder return, points to fading momentum as investors reassess growth prospects and risk. If Cognizant’s pullback has...

Catalyst Pharmaceuticals (CPRX) has been drawing attention after recent share price moves, with the stock closing at US$24.11. This has put fresh focus on how its rare disease portfolio supports the current valuation. See our latest analysis for Catalyst Pharmaceuticals. Recent trading has been relatively muted, with a 1 day share price return showing a decline of 0.78% and a 7 day share price return showing a decline of 0.90%. At the same time, a 1 month share price return of 2.25% and a...

EOG Resources (EOG) heads into its quarterly earnings announcement with investors weighing mixed analyst commentary on Texas well productivity, growing international exposure, shifting ratings, and fresh insider selling activity around the stock. See our latest analysis for EOG Resources. EOG’s share price has climbed 12.9% over the past 30 days and 16.0% over the past 90 days, even as the 1 year total shareholder return shows a 5.1% decline. This indicates recent shorter term momentum...

Zimmer Biomet Holdings stock: why investors are watching now Zimmer Biomet Holdings (ZBH) has caught investor attention after a month that included a 14.85% share price gain and annual revenue of US$8.23b, with net income of US$705.1m. See our latest analysis for Zimmer Biomet Holdings. That 14.85% 30 day share price return and 10.49% year to date share price return contrast with a 5.23% decline in 1 year total shareholder return and a 34.64% decline over 5 years. This suggests that recent...